In Vitro Models of Ovarian Cancer: Bridging the Gap between Pathophysiology and Mechanistic Models
Biomolecules · 04.01.2023 · 13 (1) · 103
DOI: 10.3390/biom13010103 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 04.01.2023. Verfasst von Elliot Lopez und 8 weiteren Autor:innen. Beteiligte Einrichtung: PASTEUR, Département de Chimie, École Normale Supérieure, PSL University, Sorbonne Université, CNRS, 75005 Paris, France. Hauptthemen laut MEDLINE: Ovarian Neoplasms. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 160 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CNRS through the MITI interdisciplinary programs and CY Initiative of Excellence.
Abstract (Originalsprache)
Ovarian cancer (OC) is a disease of major concern with a survival rate of about 40% at five years. This is attributed to the lack of visible and reliable symptoms during the onset of the disease, which leads over 80% of patients to be diagnosed at advanced stages. This implies that metastatic activity has advanced to the peritoneal cavity. It is associated with both genetic and phenotypic heterogeneity, which considerably increase the risks of relapse and reduce the survival rate. To understand ovarian cancer pathophysiology and strengthen the ability for drug screening, further development of relevant in vitro models that recapitulate the complexity of OC microenvironment and dynamics of OC cell population is required. In this line, the recent advances of tridimensional (3D) cell culture and microfluidics have allowed the development of highly innovative models that could bridge the gap between pathophysiology and mechanistic models for clinical research. This review first describes the pathophysiology of OC before detailing the engineering strategies developed to recapitulate those main biological features.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- PASTEUR, Département de Chimie, École Normale Supérieure, PSL University, Sorbonne Université, CNRS, 75005 Paris, France.
- Equipe de Recherche sur les Relations Matrice Extracellulaire-Cellules, ERRMECe, EA1391, Groupe Matrice Extracellulaire et Physiopathologie (MECuP), Institut des Matériaux, I-MAT (FD4122), CY Cergy Paris Université, CED…
ORCID-Profile: Elliot Lopez, Zixu Wang, Carole Aimé
Förderung
- CNRS through the MITI interdisciplinary programs and CY Initiative of Excellence
Zitieren
APA
Lopez, E., Kamboj, S., Chen, C., Wang, Z., Kellouche, S., Leroy-Dudal, J., Carreiras, F., Lambert, A., & Aimé, C. (2023). In Vitro Models of Ovarian Cancer: Bridging the Gap between Pathophysiology and Mechanistic Models. Biomolecules, 13(1), 103. https://doi.org/10.3390/biom13010103
Vancouver
Lopez E, Kamboj S, Chen C, Wang Z, Kellouche S, Leroy-Dudal J, et al. In Vitro Models of Ovarian Cancer: Bridging the Gap between Pathophysiology and Mechanistic Models. Biomolecules. 2023;13(1):103. doi:10.3390/biom13010103
BibTeX
@article{Lopez2023,
author = {Lopez, Elliot and Kamboj, Sahil and Chen, Changchong and Wang, Zixu and Kellouche, Sabrina and Leroy-Dudal, Johanne and Carreiras, Franck and Lambert, Ambroise and Aimé, Carole},
title = {In Vitro Models of Ovarian Cancer: Bridging the Gap between Pathophysiology and Mechanistic Models},
journal = {Biomolecules},
year = {2023},
volume = {13},
number = {1},
pages = {103},
doi = {10.3390/biom13010103}
}
EUVIMED